Warehouses and Good Distribution Practice (GSP): How Registration Binds to Physical Storage

1. Key takeaways

Medical device registration in Jordan is directly bound to a physical warehouse held in the AR’s name that has passed JFDA on-site acceptance (Scientific Office / Warehouse). GRZAN’s conclusion is that warehousing is not a logistics question but a precondition of registration — if the warehouse has not passed acceptance, the registration cannot be completed. The binding means that the quality of the warehouse becomes part of the quality of the registration itself: what happens inside the storage facility determines whether the certificate remains defensible in the market.

• Second conclusion: the warehouse must meet good distribution practice (GSP) or the storage standards set by the JFDA, and must have temperature and humidity monitoring and a segregated area for nonconforming products. These two features are the points most frequently raised at on-site acceptance. Both can be verified on site during due diligence, before any commitment is made.
• Third conclusion: changing the warehouse equals a change to the storage conditions of the registration and requires a variation filing (25 JOD). Companies that expand or change their logistics arrangements must budget for this cost and cycle. The cost and cycle should be built into the logistics plan rather than discovered afterwards.

2. Legal basis

The warehousing requirements attached to registration and distribution rest on the following instruments. The fee schedule entry is included here because the site approval fee and the variation fee both attach directly to the warehouse.

Clause numbers must be verified against the Arabic originals published in the Official Gazette of Jordan and issued by the JFDA; the amounts are the official fees listed in the JFDA fee schedule.

3. Expert insights

Insight 1: the declared storage conditions and the achieved storage conditions must be consistent. The storage condition declaration in the dossier (temperature range, humidity range, protection from light) must be capable of being met by the actual conditions of the AR’s warehouse. Where the two do not match, the compliance of the product at the circulation stage is in doubt, and the inconsistency will be pointed out directly during on-site inspection. The declaration is a regulatory commitment: once the dossier states a range, every batch stored outside that range is stored outside its approved conditions.

Insight 2: the continuity of temperature and humidity monitoring is the acceptance focus. Monitoring equipment alone is not sufficient; continuous monitoring records must be available. Interrupted records, missing data or traces of back-filled entries are among the most common negative findings at on-site acceptance. Acceptance therefore focuses on evidence of continuous operation, not on the mere presence of instruments.

Insight 3: the segregation area for nonconforming products must be independently set up. Nonconforming products, products awaiting inspection and conforming products must be physically separated to avoid mixed storage. The absence of an independent segregation area is the most common warehousing deficiency. Physical separation also supports traceability, because a segregated product can be identified and blocked before it reaches customers.

Insight 4: the site approval fee points to both the warehousing end and the production end. The JFDA fee schedule prices site approval at 700 JOD. Approval of a warehousing site and approval of a production site can each give rise to this fee, and companies should budget the two separately. Because the two ends are approved independently, a single budget line covering both avoids underestimating the total exposure.

Insight 5: cold chain products face a higher warehousing threshold. Refrigerated products require the warehouse to hold cold storage capability and full-journey temperature records. Jordan’s summer heat is severe, so the continuity of the cold chain is a particularly prominent issue in the local market. For temperature-sensitive products, the warehouse is not a passive container but an active part of product quality.

4. Practical recommendations

• Inspect the warehouse on site during the AR due diligence stage. Cross-check the JFDA acceptance documents, the continuity of the temperature and humidity monitoring records, and the independence of the segregation area for nonconforming products. The findings should be documented so that the selection decision rests on evidence rather than on representations.
• Run a matching validation between the storage conditions declared in the dossier and the capability of the warehouse. The declared temperature ranges must fall within the range the warehouse can actually control. Where the declared range sits at the edge of the warehouse capability, the margin for seasonal variation is too thin.
• Reserve the variation filing cycle and fee (25 JOD) for warehouse changes. Evaluate this cost before expanding capacity or changing the logistics arrangement.
• Verify cold chain products separately. Require the AR to provide proof of cold storage capability and samples of full-journey temperature records. This verification should be repeated whenever the cold chain arrangement changes.

5. Verification checklist

• □ Confirm that the AR’s warehouse has passed JFDA on-site acceptance
• □ Verify the continuity of the warehouse temperature and humidity monitoring records
• □ Verify that the segregation area for nonconforming products is independently set up
• □ Matching validation between the dossier storage condition declaration and the actual warehouse capability is complete
• □ Cold chain products have been verified for cold storage capability and full-journey temperature records
• □ The variation filing cycle and fee (25 JOD) have been reserved for warehouse changes
• □ A 700 JOD budget line has been reserved for site approval
• □ The cited clause numbers have been re-verified against the Arabic originals of the Official Gazette

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Jordanian market. Our team coordinates local importer arrangements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com